Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Irinotecan Sandoz eco 40 mg/2 ml"
<
Preisvergleich für Irinotecan Sandoz eco 40 mg/2 ml
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Registr. Holder
Package Size
Composition
CP
%
SB
DC
IP
Irinotecan Sandoz eco 40
mg/2 ml
Sandoz
Pharmaceuticals AG
Durchstechflasche(n)
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
57.60
10 %
IP
Irinotecan Accord 40 mg/2 ml
Accord Healthcare AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
57.25
+0%
10 %
IP
Irinotecan Fresenius 40
mg/2 ml
Fresenius Kabi
(Schweiz) AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
57.55
+0%
10 %
IP
Irinotecan-Teva liquid 40
mg/2 ml
Teva Pharma AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
57.85
+0%
10 %
IP
Irinotecan Accord 100
mg/5 ml
Accord Healthcare AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
115.40
+100%
10 %
IP
Irinotecan-Teva liquid 100
mg/5 ml
Teva Pharma AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
115.85
+101%
10 %
IP
Irinotecan Fresenius 100
mg/5 ml
Fresenius Kabi
(Schweiz) AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
116.25
+101%
10 %
IP
Irinotecan Sandoz eco 100
mg/5 ml
Sandoz
Pharmaceuticals AG
Durchstechflasche(n)
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
116.25
+101%
10 %
IP
Irinotecan Accord 300
mg/15 ml
Accord Healthcare AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
283.55
+392%
10 %
IP
Irinotecan Fresenius 300
mg/15 ml
Fresenius Kabi
(Schweiz) AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
283.55
+392%
10 %
IP
Irinotecan Sandoz eco 300
mg/15 ml
Sandoz
Pharmaceuticals AG
Durchstechflasche(n)
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
283.55
+392%
10 %
IP
Irinotecan-Teva liquid 300
mg/15 ml
Teva Pharma AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
283.55
+392%
10 %
IP
Irinotecan Accord 500
mg/25 ml
Accord Healthcare AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
405.70
+604%
10 %
IP
Irinotecan-Teva liquid 500
mg/25 ml
Teva Pharma AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
405.70
+604%
10 %
IP
Irinotecan Sandoz eco 500
mg/25 ml
Sandoz
Pharmaceuticals AG
Durchstechflasche(n)
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
410.50
+612%
10 %
IP
Irinotecan Fresenius 500
mg/25 ml
Fresenius Kabi
(Schweiz) AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
416.70
+623%
10 %
IP
Irinotecan Accord 1000
mg/50 ml
Accord Healthcare AG
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 1000mg / 50ml
PR
k.A.
For price comparison between Original and Generic please click onto the name of the drug all the way to the left!
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
